Ovidio Muniz

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A microRNA Signature for the Diagnosis of Statins Intolerance.

A microRNA Signature for the Diagnosis of Statins Intolerance.

Journal: International journal of molecular sciences

Published: June 23, 2022

High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.

High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.

Journal: Cardiovascular research

Published: May 11, 2019

Intracellular cholesterol accumulation and coenzyme Q10 deficiency in Familial Hypercholesterolemia.

Intracellular cholesterol accumulation and coenzyme Q10 deficiency in Familial Hypercholesterolemia.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: June 26, 2018

Tools to improve efficiency in the clinical management of hypertensive patients

Tools to improve efficiency in the clinical management of hypertensive patients

Journal: Hipertension y riesgo vascular

Published: March 14, 2018

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.

Journal: Journal of clinical lipidology

Published: November 21, 2016

Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.

Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.

Journal: Revista espanola de cardiologia (English ed.)

Published: July 18, 2016

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).

Journal: Circulation

Published: July 16, 2016

PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.

PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.

Journal: Atherosclerosis

Published: April 05, 2016

Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).

Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 09, 2016

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Journal: Journal of the American College of Cardiology

Published: October 21, 2015

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Journal: International journal of cardiology

Published: March 02, 2015

Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document

Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document

Journal: Semergen

Published: April 30, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026